The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Cochlear Limited has announced the launch of the Nucleus Profile Plus Series Cochlear implant.

This is designed for routine 1.5 and 3 Tesla magnetic imaging scans without the need to remove it.

This means someone with the implant doesn’t need to remove the internal magnet when going for an MRI which makes the process easier and quicker.

Cochlear has also released the Nucleus 7 Sound Processor which is currently the first and only implant which can be controlled from a phone.

The Nucleus Profile Series also includes the thinnest implants in the world and a range of electrodes individually suited which will significantly impact hearing.

Currently, it is only available in Germany with other European countries expected to follow in the coming months and other developed markets expecting to launch after regularity approvals.

Please find announcement attached here

COH by the numbers
More From The Market Online

Market shrugs as Fisher & Paykel announces mass recall

Fisher & Paykel has initiated a voluntary limited recall of batches of Airvo 1 and my…
The Market Online Video

Brian Leedman’s BlinkLab to join ASX: AI-driven smartphone app screens for autism, ADHD

BlinkLab is a world-first, AI-driven digital healthcare venture, that uses a smartphone and facial recognition to…

Osteopore stock spikes 900% on Singapore and Vietnam approvals

Osteopore's (ASX:OSX) share price was up 38% after the regenerative medicine company received approval for its…

Amplia Therapeutics takes step up in pancreatic cancer treatment

Amplia Therapeutics is on to next step in its pancreatic cancer treatment research after a successful…